Trigger Finger Treatment

February 18, 2019 updated by: ELewis, University of Massachusetts, Lowell

Trigger Finger Treatment - An Outcomes Study. Comparing 6 Traditional Treatment Techniques

Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness and/or snapping during movement. This observational study compared all of the possible treatments and combinations of treatments for trigger finger at the A1 pulley, including surgery, cortisone injections and hand therapy.

Study Overview

Detailed Description

Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness or snapping during movement. This can be very debilitating. Current treatment includes local steroid injection, oral NSAIDS, resting orthoses, physical or occupational therapy and surgical intervention. The aim of this prospective study with an observational design was to determine the outcome between surgical, hand therapy rehabilitation, and corticosteroid injection interventions for trigger finger. There were 6 treatment groups: surgery, corticosteroid injection, 1 visit of hand therapy for orthosis fabrication and therapeutic exercise, hand therapy in combination with cortisone injection, Modality hand therapy alone (ongoing visits) or with corticosteroid injections.

Study Type

Observational

Enrollment (Actual)

86

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients undergoing medical treatment or hand therapy for trigger finger in digits #2-5 at the hand clinic. Patients were dropped from the study if they had changed to a different treatment.

Description

Inclusion Criteria:

  • trigger finger in digit 2-5

Exclusion Criteria:

  • if prior treatment for trigger finger, or Trigger thumb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Surgery
Patients who underwent surgical release of A1 pulley
A1 pulley release of finger
corticosteroid injections only
Patients who underwent local corticosteroid injections only, and no other treatment
corticosteroid injection to A1 pulley
hand therapy only occupational/physical
1 visit: orthosis fabrication, range of motion, nodule and ice massage.
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education,
Other Names:
  • physical therapy
  • occupational therapy
Injection and Hand therapy
This group of participants received a combination of corticosteroid injection in the affected finger and one visit of hand therapy.
corticosteroid injection to A1 pulley
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education,
Other Names:
  • physical therapy
  • occupational therapy
Modality Hand Therapy
Ongoing hand therapy treatment, which included the above plus modalities such as ultrasound or iontophoresis.
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education, plus modalities such as ultrasound, iontophoresis
Injection and Modality Hand Therapy
Ccombination of local cortiscosteroid injection to the affected digit and ongoing hand therapy with modalities.
corticosteroid injection to A1 pulley
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education, plus modalities such as ultrasound, iontophoresis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Functional use using Quick DASH 6 weeks
Time Frame: Day 1, 6 weeks
Change from baseline to 6 weeks Quick DASH
Day 1, 6 weeks
Change in Functional use using Quick DASH 3 months
Time Frame: Day 1, 3 months
Change from baseline to 3 months Quick DASH
Day 1, 3 months
Change in Functional use using Quick DASH 6 months
Time Frame: Day 1, 6 months
Change from baseline to 6 months Quick DASH
Day 1, 6 months
Change in Edema 6 weeks
Time Frame: day 1, 6 weeks
Baseline to 6 weeks Circumferential measurement in centimeters of the proximal phalanx
day 1, 6 weeks
Change in Edema 3 months
Time Frame: day 1, 3 months
Baseline to 3 months weeks Circumferential measurement in centimeters of the proximal phalanx
day 1, 3 months
Change in Edema 6 months
Time Frame: day 1, 6 months
Baseline to 6 months weeks Circumferential measurement in centimeters of the proximal phalanx
day 1, 6 months
Change in Pain on a likert scale 6 weeks
Time Frame: 1 day, 6 weeks
Baseline to 6 weeks pain on a 0-10 scale
1 day, 6 weeks
Change in Pain on a likert scale 3 months
Time Frame: 1 day, 3 months
Baseline to 3 months pain on a 0-10 scale
1 day, 3 months
Change in Pain on a likert scale 6 months
Time Frame: 1 day, 6 months
Baseline to 6 months pain on a 0-10 scale
1 day, 6 months
Change in Range of motion 6 weeks
Time Frame: 1 day, 6 weeks
Baseline to 6 weeks flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
1 day, 6 weeks
Change in Range of motion 3 months
Time Frame: 1 day, 3 months
Baseline to 3 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
1 day, 3 months
Change in Range of motion 6 months
Time Frame: 1 day, 6 months
Baseline to 6 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
1 day, 6 months
Change in Severity or Grade of triggering 6 weeks
Time Frame: 1 day, 6 weeks
Baseline to 6 weeks Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
1 day, 6 weeks
Change in Severity or Grade of triggering 3 months
Time Frame: 1 day, 3 months
Baseline to 3 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
1 day, 3 months
Change in Severity or Grade of triggering 6 months
Time Frame: 1 day, 6 months
Baseline to 6 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
1 day, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 10, 2007

Primary Completion (ACTUAL)

December 8, 2012

Study Completion (ACTUAL)

December 8, 2012

Study Registration Dates

First Submitted

February 8, 2019

First Submitted That Met QC Criteria

February 18, 2019

First Posted (ACTUAL)

February 20, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 20, 2019

Last Update Submitted That Met QC Criteria

February 18, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There are no plans for sharing the IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Finger

Clinical Trials on surgery

3
Subscribe